Читать книгу Canine and Feline Epilepsy - Luisa De Risio - Страница 68
Structural (symptomatic or secondary) epilepsy
ОглавлениеThe terms symptomatic epilepsy and secondary epilepsy have both been used to indicate recurrent seizures caused by a known and identifiable structural forebrain disorder such as vascular, inflammatory/infectious, traumatic, anomalous/developmental, neo-plastic and degenerative diseases. The term structural epilepsy, introduced by the ILAE 2010 proposal, should be adopted also in veterinary medicine as its meaning indicates more clearly epilepsy resulting from structural forebrain disease. The term secondary is too generic and prone to misuse, indeed, it has sometimes been used in the veterinary literature to refer to seizures caused by structural forebrain disorders as well as metabolic or toxic disorders (Pákozdy et al., 2010) generating confusion when attempting study comparison. The term symptomatic is a truism as recurrent seizures (epilepsy) are the symptom in humans and the clinical sign in animals of an underlying disease.
Dogs and cats with structural epilepsy usually present with neurological signs (other than seizures) interictally. However, focal lesions in particular areas of the brain (‘clinically silent regions’), such as olfactory bulb and frontal lobes, can result in seizure activity without any other neurological signs (Foster et al., 1988; Smith et al., 1989). Aetiologies of structural epilepsy are listed in Box 3.2 and described in detail in Chapter 5.
Table 3.3. Veterinary classification of seizures and epilepsies based on underlying aetiology, parallelism with the ILAE 2010 proposed new terminology, and terminology used in this book.
Current veterinary terminology | ILAE 2010 proposed new terminology | Terminology used in this book |
Reactive seizures | Metabolic | Reactive seizures |
Symptomatic or secondary epilepsy | Structural epilepsy | Structural epilepsy |
Probable symptomatic or cryptogenic epilepsy | Epilepsy of unknown aetiology | Cryptogenic epilepsy |
Idiopathic or primary epilepsy | Genetic | Idiopathic epilepsy |
Box 3.1. Aetiologies of reactive seizures.
Metabolic
Hepatic disease
congenital and acquired portosystemic shunt, microvascular dysplasia, hepatic lipidosis, neoplasia, inflammation
Renal disease
acute renal failure, end-stage chronic renal failure
Electrolyte imbalance
hypo- or hypernatraemia, hypocalcemia
Hypoglycaemia
insulin-secreting tumour, severe sepsis, iatrogenic insulin overdose
Hypoxia
Hypertension
Polycythaemia
Nutritional
Thiamine deficiency
Toxicity
Pyrethrins/ Pyrethroids, organophosphates, chlorinated hydrocarbons carbamate
Metaldehyde
Strychnine, bromathalin
Sodium monofluoroacetate (compound 1080)
Ethylene glycol
Detergents and disinfectants
Lead and other heavy metals
Poisonous plants
Mycotoxins (penitrem A, roquefortine)
Animal-related poisoning (toad, spider, bee and wasp venom)
Metronidazole (cats)
5-hydroxytryptophan
Caffeine and other methylxanthines
Amphetamine and amphetamine-like compounds
Selective serotonin reuptake inhibitors
Classification of certain disorders may be open to debate. For example, organic acidurias such as L-2-hydroxyglutaric aciduria in Staffordshire bull terriers may be classified as structural epilepsy as they result in MRI and histological changes in the brain as well as metabolic disorders as they are caused by an error of cellular metabolism, or genetic epilepsy, as the underlying genetic mutation is known (Abramson et al., 2003; Penderis et al., 2007).
Box 3.2. Aetiologies of structural epilepsy.
Vascular
Cerebrovascular disease (ischaemic, haemorrhagic)
Inflammatory/ infectious
Viral
Bacterial
Rickettsial
Protozoal
Mycotic
Parasitic
Mycoplasmosis
Algal
Granulomatous meningoencephalomyelitis
Necrotizing meningoencephalitis
Necrotizing leukoencephalitis
Other feline and canine meningoencephalitis or meningoencephalomyelitis of unknown aetiology Traumatic brain injury Anomalous and developmental
Hydrocephalus
Hydranencephaly
Porencephaly
Meningoencephalocele
Meningoencele
Exencephaly
Holoprosencephaly
Agenesis of the corpus callosum
Lissencephaly
Polymicrogyria
Cerebral neuronal heterotopias or dysplasias
Neoplastic
Primary
Meningioma
Astrocytoma (glioblastoma multiforme)
Oligodendroglioma
Gliomatosis cerebri
Ependymoma
Choroid plexus tumours
Primitive neuroectodermal tumours (neuroblastomas, medulloblastoma, gangliocytomas)
Primary CNS lymphomas
Primary CNS histiocytic sarcoma (malignant histiocytosis)
Secondary
Haemangiosarcoma
Lymphoma
Pituitary Tumours
Carcinomas/ Adenocarcinomas (mammary, prostatic, pancreatic, pulmonary)
Nasal tumours (e.g. adenocarcinoma, squamous cell carcinoma, chondrosarcoma, neuroesthesioblastoma)
Histiocytic sarcoma
Calvarial osteosarcoma and multilobulated tumour of bone (multilobulated osteochondrosarcoma)
Malignant melanoma
Others
Degenerative
Lysosomal storage diseases
Organic acidurias
Mitochondrial encephalopathies and encephalomyelopathies
Leukodystrophies
Spongy degenerations
Multisystem neuronal degeneration/abiotrophy